Our participants had an a priori high risk of AD, as reflected in a family history and/or APOE-4 genotype, and brain analyses focused on AD-vulnerable regions, enhancing the statistical and anatomical likelihood that the observed brain effects may be related to an AD predisposition. The gene discussed is APOE; the disease is Alzheimer disease.